A listing of Suicide medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
The research study is being conducted to study brain patterns of negative emotion and develop personalized brain stimulation protocols to disrupt these patterns with transcranial magnetic stimulation (TMS). First, we will use functional Magnetic Resonance Imaging (fMRI) data to generate a negative affect map for each subject. Then, we will …
The research study is being conducted to test the efficacy of a new psychotherapeutic strategy, closed loop real time fMRI neurofeedback, in reducing negative attention bias and depressive symptoms. Participants are being asked to voluntarily participate in a research study because they are between the ages 18-65 and currently experiencing …
The goal of this study is to further our understanding of the relationship between depression and hypersomnia by examining mood-relevant domains of slow wave sleep and reward function.
The research study is being conducted to determine if active VNS (Vagus Nerve Stimulation) Therapy helps depression subjects compared to a no-stimulation control group. Patients with an established diagnosis with Treatment-Resistant Depression (TRD) and have been referred for treatment with the VNS Therapy® System will potentially qualify to participate in …
The purpose of this research study is to evaluate whether adding stimulation of the subcallosal cingulate white matter using the investigational Infinity Deep Brain Stimulation (DBS) system in treatment of Major Depressive Disorder is safe and beneficial. This study is looking for 6 patients with Major depressive disorder to participate. …
The study will investigate 20 mg seltorexant as adjunctive treatment to SSRI/SNRI antidepressants for major depressive disorder (MDD) compared with placebo as adjunctive therapy in patients with a partial response to first line antidepressant therapy.
The purpose of this research study is to determine whether the study drug, Solriamfetol, is safe and effective for the treatment of Major Depressive Disorder (MDD). Solriamfetol, also called Sunosi®, is approved by the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) for people who …
A single site, 3-arm (CBT-I group; Bright Light Therapy group; Standard of Care group), parallel, randomized controlled trial in subjects with insomnia, fatigue and PAH will be conducted. Primary Objective To assess the feasibility (recruitment and retention rates) of CBT-I and Bright Light Therapy in patients with PAH. Secondary Objectives …
Primary Objective: To compare the efficacy of 2 doses of BHV-7000 to placebo as an adjunctive therapy for refractory focal onset epilepsy as measured by the change from baseline in 28-day average seizure frequency. Secondary Objcetives: -To compare the efficacy of 2 doses of BHV-7000 to placebo as adjunctive therapy …
The 5-year K01 Mentored Research Scientist proposal will employ brain, neurocognitive, and computational tools (e.g., machine learning) to understand the impact of opioid-use disorder (OUD) and common co-occurring issues on executive function and clinical outcomes.